• Follow @TheHPRA
  • Contact us
  • Glossary
  • As Gaeilge
The Health Products Regulatory Authority logo
My HPRA: Login Register
  • About Us
  • Medicines
  • Veterinary
  • Medical Devices
  • Blood, Tissues, Organs
  • Cosmetics
  • Controlled Substances
  • Medicines
  • Regulatory Information
  • Product Information Update (PIU)
  • PIU letters for healtchare professional
My HPRA: Login Register
  • About Us
  • Medicines
    • Our Role
    • Medicines Information
    • Safety Information
    • Safety Notices
    • Quality Information
    • Regulatory Information
      • Classification of Medicines
      • Medicines Authorisation
      • Pharmacovigilance and Post Authorisation Safety
      • Clinical Trials
      • Generic and Interchangeable Medicines
      • Manufacturers
      • Wholesale Distribution
      • Retailers
      • Market Compliance and Surveillance
      • Medicine Fees
      • Export Certification
      • Consultations
      • Product Information Update (PIU)
        • PIU letters for healtchare professional
      • National Scientific and Regulatory advice
      • Information for Brokers
      • Active Substance Registrations
    • News & Events
    • Special Topics
    • Emergency Medicines
  • Veterinary
  • Medical Devices
  • Blood, Tissues, Organs
  • Cosmetics
  • Controlled Substances

PIU letters sent to healthcare professionals can be found below

  • Baxter Electrolyte Solutions for Infusion 01.10.2019

  • MSD Ireland - Sinemet 22.05.2019 

  • Tegretol - Product Range (PA0896/030/001-006)

  • Pfizer - Solu-Medrone 40mg and 125mg: New Prescribing Information

  • Azzalure, - CRN2198923 (CRN008LD2)

  • Curium Life Forward - Ultra-Technekow FM, 2.15-43.00 GBq, radionuclide generator

  • GlaxoSmithKline - Amoxil Vials 500 mg, powder for solution for injection or infusion, PA 1077/33/4

  • Johnson & Johnson Miconazole (Daktarin) 20 mg/g oral gel: co-administration with warfarin now contraindicated except when Daktarin oral gel is specifically prescribed and used under medical supervision with close monitoring of INR

  • Solu-Medrone information update HCP -Nov 2017

  • Glucohage update - June 2016 

  • Product Information Update for Amoxil - GSK - April 2017

  • Innohep 10,000 IU/ml Vial and Syringes - Leo Pharma 15.03.2017

  • Sanofi, update of warning relating the risk in patients with ischaemic heart disease.

  • Levonorgestrel-containing medicines for emergency hormonal contraception 13.12.2016

  • HPRA notice for Levonorgestrel 13.12.2016 

  • Innohep 20,000 IU/ml Vial and Syringes - Leo Pharma 15.11.2016

  • Videx PIU letter 23.05.2016

  • BCH letters 16.03.16

  • Orap letter 25.02.2016

  • Decapeptyl letter

  • Targocid letter

  • Zinnat letter 

  • Caverject letter

  • Sublimaze letter

 





About Us

  • Our vision, mission and values
  • How We Regulate
  • Contact Us
  • Our Structure
  • Standards of Service
  • Information and transparency
  • Privacy and Data Protection
  • Consultations
  • Quality Management
  • Recruitment
  • Publications & Forms
  • Report an Issue
  • Legislation
  • Extranets
  • News and Events
  • Information Campaigns

Medicines

  • Our Role
  • Medicines Information
  • Safety Information
  • Safety Notices
  • Quality Information
  • Regulatory Information
  • News & Events
  • Special Topics
  • Emergency Medicines

Veterinary

  • Our Role
  • Veterinary Medicines Information
  • Safety Information
  • Regulatory Information
  • Veterinary News & Events
  • Special Topics
  • Contact details
  • Scientific Animal Protection
  • Availability of veterinary medicines in Ireland

Medical Devices

  • Our Role
  • Safety Information
  • Regulatory Information
  • Medical Devices News & Events
  • Special Topics
  • Register Medical Devices Extranet
  • Medical Device Economic Operators in Ireland

Blood, Tissues, Organs

  • Our Role
  • Blood
  • Tissues and Cells
  • Organs
  • Blood and Tissues Establishments List
  • Inspection Process
  • Special Topics
  • News and Events
  • Safety Notices

Cosmetics

  • Our Role
  • Safety Information
  • Regulatory Information
  • News & Events
  • Special Topics

Controlled Substances

  • Our Role
  • Controlled Drugs
  • Precursor Chemicals

Website Information

  • Register for Alerts
  • Glossary
  • Terms of Use
  • Privacy and Cookie
  • Contacts
  • Links
  • FOI
  • Sitemap
 

© Health Products Regulatory Authority 2014

Contact Us

Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland, D02 XP77

  • +353 (1) 676 4971
  • info@hpra.ie
  •  
  • Follow @TheHPRA
 
 

Developed by Engine Solutions

Important information regarding cookies and the HPRA

By using this website, you consent to the use of cookies in accordance with the HPRA Cookie Policy.
For more information on cookies, see our cookie policy.

Click here to accept the cookie policy and hide this message
Reset Cookie
Date Printed: 12/12/2019